Advertisement

Pharmacological Studies with New Liposome-Entrapped Cisplatin Derivatives

  • Roman Perez-Soler
  • Zahid H. Siddik
  • Kiumars Vadiei
  • Irwin H. Krakoff
  • Abdul R. Khokhar

Abstract

Therapy for disseminated human cancer is limited by the low degree of tumor selectivity with the antitumor agents currently available. The development of succesful ways to target cytotoxic agents to tumor sites is, therefore, important but, as yet, the approach is still in its infancy. Different types of drug carriers have been considered for that purpose and, among those, liposomes continue to attract significant attention. During the last few years, there has been steady progress in the liposome field, mainly in trying to solve some of the well recognized limitations of lipid vesicles as drug carriers in general, and as carriers of antitumor agents in particular: formulation, scaling up, and tumor targeting properties.

Keywords

Hepatic Artery Lipid Bilayer Platinum Compound LoVo Cell Multilamellar Vesicle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gabizon A, Price DC, Huberty J, Bresalier RS, Papahadjopoulos D. Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies. Cancer Res 50:6371–6378, 1990.PubMedGoogle Scholar
  2. 2.
    Wang CY and Huang L. PH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proc Natl Acad Scie USA 84:7851–7855, 1987.CrossRefGoogle Scholar
  3. 3.
    Khokhar AR, S Al-Baker, IH Krakoff, R Perez-Soler: Toxicity and antitumor activity of cis-bis-carboxylato (trans-R,R-l,2-diaminocyclohexane) platinum (II) complexes entrapped in liposomes, a new series of lipid-soluble drugs. Cancer Chemother Pharmacol. 23:219–224, 1989.PubMedCrossRefGoogle Scholar
  4. 4.
    Perez-Soler R, G Lopez-Berestein, J Lautersztain, S Al-Baker, K Francis, D Macias-Kiger, MN Raber, AR Khokhar. Phase I clinical and pharmacology study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II). Cancer Res. 50:4254–4259, 1990.PubMedGoogle Scholar
  5. 5.
    Perez-Soler R, J Lautersztain, LC Stephens, K Wright, AR Khokhar: Pharmacology and toxicity of liposome entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II) in mice and dogs. Cancer Chemother Pharmacol. 24:1–8, 1989.PubMedCrossRefGoogle Scholar
  6. 6.
    Perez-Soler R, LY Yang, B Drewinko, J Lautersztain, AR Khokhar: Increased cytotoxicity and reversal of resistance to cis-diamminedichloro-platinum (II) with entrapment of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in multilamellar vesicles. Cancer Res 48:4509–4512, 1988.PubMedGoogle Scholar
  7. 7.
    Perez-Soler R, AR Khokhar, G. Lopez-Berestein: Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II) encapsulated in multilamellar vesicles. Cancer Res 47:6462–6466, 1987.PubMedGoogle Scholar
  8. 8.
    Lautersztain J, R Perez-Soler, AR Khokhar, RA Newman, G Lopez-Berestein: Pharmacokinetics and tissue distribution of liposome-encapsulated cis-bis-N-decyl-iminodiacetato-1,2-diaminocyclohexane platinum (II). Cancer Chemother Pharmacol 18:93–97, 1986.PubMedCrossRefGoogle Scholar
  9. 9.
    Perez-Soler R, AR Khokhar, J Lautersztain, PA Mitchell, KL Schmidt: Ultrastructural and freeze fracture localization of multilamellar liposomes containing a lipophilic cisplatin analogue in normal tissues and liver metastases of M5076 reticulosarcoma. Cancer Drug Deliv 4:75–88, 1987.PubMedCrossRefGoogle Scholar
  10. 10.
    Lautersztain J, R Perez-Soler, J Turpin, AR Khokhar, ZH Siddik, K Schmidt, G Lopez-Berestein: Cellular pharmacology of liposome entrapped cis-bis-neodecanoato-trans R,R-1,2-diaminocyclohexane platinum (II). Cancer Res 48:1300–1306, 1988.PubMedGoogle Scholar
  11. 11.
    Khokhar AR, Wright K, ZH Siddik, R Perez-Soler: Organ distribution and tumor uptake of liposome entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II) administered intravenously and into the proper hepatic artery. Cancer Chemother Pharmacol 22:223–227, 1988.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Roman Perez-Soler
    • 1
  • Zahid H. Siddik
    • 1
  • Kiumars Vadiei
    • 1
  • Irwin H. Krakoff
    • 1
  • Abdul R. Khokhar
    • 1
  1. 1.Department of Medical OncologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations